Introduction {#Sec1}
============

Lung cancer is one of the most common causes of cancer morbidity and mortality worldwide; it accounts for about 11.6% of the total diagnosed cases and 18.4% of the total cancer deaths, with the age-standardized rate of 22.5 new incidence cases per 100,000 and age-standardized rate of 18.6 new death cases per 100,000, based on the GLOBOCAN estimates of global cancer incidence, mortality, and prevalence (Ferlay et al. [@CR10]). China has one of the highest disease burden levels of lung cancer in the world (Torre et al. [@CR30]). According to the latest Chinese cancer registration annual report, the raw incidence rate of lung cancer in 2014 was 77.42 per 100,000 men and 40.10 per 100,000 women.

A growing body of epidemiological studies showed that particulate matter (PM), especially fine particulate matter of aerodynamic diameter \< 2.5μm (PM~2.5~), has an adverse effect on human health (Fajersztajn et al. [@CR9]; Kampa and Castanas [@CR17]), especially for lung cancer (Wang et al. [@CR35]; Dehghani et al. [@CR7]) as well as cardiovascular diseases (Zhang et al. [@CR38], [@CR39]; Beelen et al. [@CR3]). What's more, the International Agency for Research on Cancer (IARC) concluded that exposure to PM from outdoor air pollution is carcinogenic to humans (IARC group 1) and causes lung cancer (Loomis et al. [@CR22]). Similar findings were also obtained in cohort studies from Europe, North America, and Asia. For example, in Europe, evidence from 17 cohorts suggested that a statistically significant association between risk for lung cancer incidence and PM~2.5~, the hazard ratio (HR), was 1.18 (0.96--1.46) per 5 μg/m^3^ (Raaschou-Nielsen et al. [@CR26]). In the USA, a large cohort study examined associations between long-term ambient PM~2.5~ concentrations and lung cancer mortality in lifelong never smoke and found a 15--27% increase in lung cancer mortality for each \> 10 μg/m^3^ increase in PM~2.5~ concentrations (Turner et al. [@CR31]). In China, a 12-year cohort study conducted in northern China indicated that each 10 μg/m^3^ increase in PM~10~ concentration was associated with a 3.4--6.0% increase in lung cancer mortality, and the association was various in men and women (Li et al. [@CR20]).

In addition to epidemiological study of lung cancer and PM~2.5~, the spatial distribution of PM~2.5~ also makes a specific contribution to lung cancer mortality and morbidity. As a consequence of reform and opening up, China has been experiencing high concentrations of air pollution (Brauer et al. [@CR5]). The serious PM~2.5~ pollution issue in China has attracted great attention in recent years, and the large quantities of air pollutants indicate that PM~2.5~ pollution has expanded over a large regional scale (Li et al. [@CR23]; Hu et al. [@CR15]). Recent studies in some mega-cities of China have focused on the characteristics, chemical compositions, sources, and formation mechanism of PM~2.5~ (Li et al. [@CR19]; Gao et al. [@CR12]; Zheng et al. [@CR40]). Specifically, densely populated mega-cities worsen the situation that the transport of pollutants may cross over geographical broader and contributes significantly to the formation of secondary aerosol (Huang et al. [@CR16]). Moreover, due to a large amount of anthropogenic emissions, the impact of long-range transport of pollutants from China may affect the Pacific Ocean, other countries in Asia, and even North America (Wuebbles, Lei, and Lin [@CR36]). Thus, these findings suggest that the regional transport of air pollutants may play an important role in the formation of PM~2.5~ pollution and spatial inequity of lung cancer.

To provide a reference to investigate the association between lung cancer mortality, morbidity, and long-term PM~2.5~ pollution, it is necessary to obtain detailed information about the local and regional variation of lung cancer mortality and morbidity and PM~2.5~ concentration. Therefore, in this study, we first investigated the association between lung cancer mortality and morbidity with local and regional PM~2.5~ concentrations. Secondly, the concentration-response functions between the annual lung cancer outcomes and long-term exposure to PM~2.5~ concentrations by five forecasting models were established. Finally, we obtained the forecasting spatial distribution of lung cancer mortality and morbidity in China.

Materials and methods {#Sec2}
=====================

Materials and data processing {#Sec3}
-----------------------------

### Lung cancer mortality and morbidity data {#Sec4}

Lung cancer mortality and morbidity (ICD-10, C33-C34) were collected from the Chinese cancer registry annual report from 2009 to 2017, released by the National Central Cancer Registry (NCCR) and Disease Prevention and Control Bureau, Ministry of Health. The NCCR evaluated the registry data based on the criteria of quality control in the program protocol. According to the results of quality control, only data with good completeness and validity, according to the registries, were selected and analyzed for mortality and morbidity of cancer in China. All data on lung cancer mortality and morbidity are reported to population-based cancer registries in the centers for disease control, cancer hospital, or institute of cancer prevention and control.

A total of 1294 cancer registries were reported from 2006 to 2014; among those cancer registries, only few of the cancer registries published continuous data from 2006 to 2014; many new cancer registries reported cancer data during 2010--2014; thus, the whole lung cancer dataset was an unbalanced panel (see Table [1](#Tab1){ref-type="table"}). By 2014, 339 cancer registries submitted data and qualified, with data distributed in 31 provinces and municipalities, including 129 urban areas and 210 rural areas. The population covered by cancer registration areas in 2014 was 288,243,347 (146,203,891 males and 142,039,456 females), which accounted for 21.07% of the entire national population. In the present study, cancer registries were not selected wherein the lung cancer mortality or morbidity was 0. Similarly, cancer registries were selected wherein lung cancer mortality or morbidity was great than 0. Besides, due to the small spatial scale of cancer registry areas, we grouped these areas into a large scale and recalculated the mortality and morbidity using their total combined population. Finally, a total of 1194 cancer registries from 2006 to 2014 were obtained in the present study, and the annual lung cancer mortality and morbidity were agreed, as the death and incidence of newly increasing lung cancer cases occurred in a single year for the covered population.Table 1Descriptions for cancer registration areas from 2006 to 2014YearNo. of registriesNo. of urban registriesNo. of rural registriesPopulation (10 thousands)200634151959562007381721598020084120216613200972314184472010145588712,46520111777710014,57520121937312019,80620132558816722,649201433912921028,824

The classification of Eastern areas, Middle areas, and Western areas is based on the standard of the National Statistics Bureau. Eastern areas consist of Beijing, Tianjin, Hebei, Liaoning, Shanghai, Jiangsu, Zhejiang, Fujian, Shandong, Guangdong, and Hainan. Middle areas consist of Heilongjiang, Jilin, Shanxi, Anhui, Jiangxi, Henan, Hubei, and Hunan. Western areas consist of Inner Mongolia, Guangxi, Chongqing, Sichuan, Guizhou, Yunnan, Tibet, Shaanxi, Gansu, Qinghai, Ningxia, and Xinjiang. Figure [1](#Fig1){ref-type="fig"} and Fig. [S1](#MOESM1){ref-type="media"} shows the spatial distribution of the cancer registries in this study.Fig. 1Spatial distribution of the cancer registries in 2014 across China

### Satellite-derived annual PM~2.5~ concentration data {#Sec5}

The annual means of global PM~2.5~ concentration at 0.01° × 0.01° spatial resolution were collected from the Atmospheric Composition Analysis Group website of Dalhousie University. Van Donkelaar et al. estimated the global PM~2.5~ concentrations using multiple satellite products (MISR, MODIS Dark Target, MODIS and SeaWiFS Deep Blue, and MODIS MAIAC) (van Donkelaar et al. [@CR33]; van Donkelaar et al. [@CR32]).

To avoid the bias of uninhabited areas, such as the Taklimakan Desert, where few people live and the lung cancer mortality and morbidity are almost zero. Therefore, the dust- and sea salt-removed annual PM~2.5~ concentrations with 0.01° × 0.01° spatial resolution dataset were used in this study. For each cancer registry area, we first spatially matched the polygon shapefile of the cancer registry area with global surface annual PM~2.5~ concentration data and then calculated the annual mean PM~2.5~ concentration using the data of the grid point that fall within each cancer registry area from 1998 to 2016.

### Conceptual framework {#Sec6}

Based on the abovementioned background, we developed our conceptual framework and summarized it in Fig. [2](#Fig2){ref-type="fig"}. We proposed that the mortality and morbidity of lung cancer were not only under the influence of local PM~2.5~ pollution, but also the regional PM~2.5~ pollution. Figure [2](#Fig2){ref-type="fig"} displays the conceptual framework of this study, with spatial influence representing the PM~2.5~ concentration from the local area and surrounding areas, temporal influence representing the lag effect in PM~2.5~ concentration, and lung cancer exposure-response relationship.Fig. 2The conceptual framework

In this study, a contiguity-based conceptualization was constructed, where the definition of the neighborhood is based on sharing a common boundary or node for a specific area. Then, the mean value of all surrounding PM~2.5~ concentrations represented the regional scale. The definition of regional scale can be determined as follows:$$\documentclass[12pt]{minimal}
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                \begin{document}$$ \mathrm{reg}=\frac{\sum_{i=1}^n\mathrm{P}{\mathrm{M}}_{2.{5}_i}}{n} $$\end{document}$$where PM~2.5~ is the area unit concentration, *n* is the total number of neighborhoods, and *i* is a certain neighbor. More importantly, previous studies have revealed the relationship between time lag from the exposure of PM~2.5~ and the development of lung cancer mortality and morbidity (Han et al. [@CR13]; Sloan et al. [@CR28]; Biggeri et al. [@CR4]). It is confirmed that prolonged high exposure to PM~2.5~ adversely influences lung cancer risk. Moreover, studies from the major cities of China have shown that the time lag of PM~2.5~ exposure to lung cancer morbidity and/or mortality is 7 to 8 years (Chen, Li, and Zhou [@CR6]; Zhang [@CR38], [@CR39]). Therefore, in this study, two group variables represent the regional effect and lag effect in PM~2.5~ concentration and lung cancer exposure-response relationship. The definition of exposure-response relationship can be determined as follows:$$\documentclass[12pt]{minimal}
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Methods {#Sec7}
-------

### Spatial autocorrelation analysis {#Sec8}

The Globe Moran's *I* is a measure of spatial autocorrelation developed by Moran (Moran [@CR24]). The Globe Moran's *I* has been widely used in public health to investigate spatial clusters of cancer (Zhang and Nitin [@CR37]; Kulldorff et al. [@CR18]). We figured out the Globe Moran's *I* statistics in ArcGIS 10.1 to examine the spatial autocorrelation of lung cancer mortality and morbidity and the PM~2.5~ concentration in China. The equation for Moran's *I* statistic is as follows:$$\documentclass[12pt]{minimal}
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The spatial relationships among counties or cities were characterized by the spatial weight matrix (Anselin [@CR1]). In our study, an inverse distance matrix, which defines the impact of one feature on another feature and decreases with distance, was used for spatial weights. An inverse distance weights matrix was constructed in ArcGIS by using the county-level point-shape file. To our knowledge, there is no consistent evidence showing a fixed distance to characterize the impact of PM~2.5~, and the variation that distance may have an influence on Moran's *I*. Thus, we prefer a default distance to construct the weight matrix.

### Forecasting models {#Sec9}

As aforementioned, due to the influence of regional transportation of PM~2.5~ pollutant, two group variables were used to establish the five alternative forecasting models, including the ridge regression model, the partial least squares regression model, the model tree-based regression model, the regression tree approach, and the combination forecasting model. Text [S1](#MOESM1){ref-type="media"} provided detailed information about five forecasting models. To evaluate the performance of alternative models, the error analysis was conducted to measure the accuracy between the observed and predicted lung cancer mortality and morbidity. Mean square error (MSE), mean absolute error (MAE), mean absolute percentage error (MAPE), Theil inequality coefficient (Theil IC), bias proportion (BP), variance proportion (VP), and covariance proportion (CP) are model evaluation indices which were used to measure the error of the lung cancer mortality and morbidity. These evaluation indices are expressed as$$\documentclass[12pt]{minimal}
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To avoid selection bias, first, we randomly divided lung cancer data into a training set and a testing set (90% training and 10% testing), and 10% of the lung cancer data was used to verify the alternative forecasting models. Then, we conducted the aforementioned forecasting process for 1000 loops as cross-validation. Thus, the mean value and standard deviation of the result of error analysis were given in this study, besides various proportion of training and testing sets for further verification (85%, 80%, 75%, and 70% for the training set; 15%, 20%, 25%, and 30% for the testing set). Then, the best performing model was used to construct the forecasting model, based on lung cancer mortality and morbidity from 2006 to 2014. Finally, annual lung cancer mortality and morbidity for 2408 counties across China from 2015 to 2016 were obtained by the forecasting model, and the gridded spatial distributions of lung cancer mortality and morbidity in 2015 to 2016 were obtained by using the Kriging interpolation in ArcGIS 10.2.

Results {#Sec10}
=======

Lung cancer mortality and morbidity in China {#Sec11}
--------------------------------------------

There were a total of 720,563 and 595,002 lung cancer morbidity and mortality cases reported in China from 2006 and 2014, of which 481,413 (66.8%) were male and 239,277 (33.2%) were female morbidity, and 404,679 (68.01%) were male and 190,323 (31.99%) were female mortality. Within both male and female groups, it was shown that urban areas have higher rates of lung cancer morbidity and mortality. Table [S1](#MOESM1){ref-type="media"} shows the morbidity and mortality of lung cancer from 2006 to 2014. The crude rate of lung cancer morbidity and mortality showed an increasing trend in this period. Figure [S2](#MOESM1){ref-type="media"} presents the spatial distribution of morbidity and mortality of lung cancer in 2014 in 307 registries. Figures [S3](#MOESM1){ref-type="media"}-[S4](#MOESM1){ref-type="media"} show the spatial distribution of morbidity and mortality of lung cancer in China from 2006 to 2013. There were obvious spatial variations in the rate of lung cancer morbidity and mortality. The highest rates of lung cancer morbidity and mortality mainly located in the provinces of Liaoning, Shandong, Hebei, and Jiangsu, which are located in the eastern area of China.

Spatial distribution of PM~2.5~ {#Sec12}
-------------------------------

The spatial distribution of the multi-year (1998--2016) average PM~2.5~ concentration in China is shown in Fig. [3](#Fig3){ref-type="fig"}. Most of the high PM~2.5~ concentration appeared in densely populated areas east of the Hei-Tengchong Line, which was proposed by Hu Huanyong in 1935 to illustrate China's demographic distribution. There was a significant difference in the spatial patterns of the annual mean PM~2.5~ for eastern and western China. The overall average PM~2.5~ concentration for eastern China was two times higher than that for western China. For 1194 cancer registry areas, 1192 areas had annual mean PM~2.5~ concentrations greater than 10 μg/m^3^, the WHO air quality guidelines (AQG) recommendation for PM~2.5~ annual mean concentrations. There were 1167 cancer registry areas with annual mean PM~2.5~ concentrations greater than 15 μg/m^3^ (WHO Interim target-3 (IT-3)), 1033 cancer registry areas with annual mean PM~2.5~ concentrations greater than 25 μg/m^3^ (WHO Interim target-2 (IT-2)), and 859 cancer registry areas with annual mean PM~2.5~ concentrations greater than 35 μg/m^3^ (WHO Interim target-1 (IT-1)), that means more population were exposed to high levels of PM~2.5~ concentration.Fig. 3The spatial distribution of the multi-year (1998--2016) average PM~2.5~ concentration in China

Pearson correlation analysis {#Sec13}
----------------------------

The results from the Pearson correlation analysis showed a positive and significant association between lung cancer outcomes (mortality and morbidity) and the two group variables at the 0.01 level. As seen in Table [2](#Tab2){ref-type="table"}, the correlation of the current year PM~2.5~ concentration was slightly lower than the lag correlations. Compared with the local lag and regional lag exposure to ambient PM~2.5~, the regional lag effect was not stronger than the local lag PM~2.5~ exposure, which may depend on the apportionment of surrounding PM~2.5~ concentration. Generally, both local and regional lag had long and positive effects on lung cancer mortality and morbidity.Table 2The Pearson correlation degree between lung cancer outcomes (mortality and morbidity) and PM2.5 concentration in China from 2006 to 2014LagLag 0Lag 1Lag 2Lag 3Lag 4Lag 5Lag 6Lag 7Lag 8Mortality0.2490.2510.2470.2720.2860.2910.2990.2870.294Morbidity0.2150.2250.2170.2440.2650.2800.2990.2890.301Spatial lagSlag 0slag 1slag 2Slag 3Slag 4Slag 5Slag 6Slag 7Slag 8Mortality0.1720.1850.1870.2170.2200.2240.2330.2210.235Morbidity0.1460.1640.1610.1940.2040.2210.2380.2310.249Correlation is significant at the 0.01 level

Globe spatial autocorrelation {#Sec14}
-----------------------------

The Globe Moran's *I* statistics showed that the mortality and morbidity of lung cancer exhibited significant spatial autocorrelation for each year in China. The mortality and morbidity of lung cancer showed positive spatial autocorrelation of less than a 1% significance level, according to the results of Global Moran's *I* statistics (as presented in Table [S2](#MOESM1){ref-type="media"}). On the other hand, the annual PM~2.5~ concentration also had significant and positive spatial autocorrelation for each year (see Table [S3](#MOESM1){ref-type="media"}). As shown, an increasing trend was found in the *Z*-score of Globe Moran's *I* statistics, which indicates that it is less possible for PM~2.5~ in a region to follow the random distribution. Higher Moran's *I* statistics of PM~2.5~ concentration, which were observed in 2009--2014, ranged from 0.525 to 0.708.

Forecasting PM~2.5~-induced lung cancer mortality and morbidity {#Sec15}
---------------------------------------------------------------

As shown in Table [3](#Tab3){ref-type="table"}, the lung cancer mortality and morbidity prediction by the combination forecasting model had the lowest MSE, MAE, MAPE mean value, and higher CP value among the five forecasting models, which indicates that the combination forecasting model was performed better than the other models. The results of the sensitivity analysis (see Table [S4](#MOESM1){ref-type="media"} and [S5](#MOESM1){ref-type="media"}), where various proportion for training and testing data sets was used to test the validation of five alternative forecasting models, further confirmed that the combination forecasting model was the best performed.Table 3Model evaluation of five alternative forecasting modelsRRPLSRRTMTCFMMortality  MAE11.08 (0.75)11.16 (0.78)11.38 (0.79)11.08 (0.83)10.89 (0.76)  MSE195.96 (25.42)199.28 (26.38)207.67 (27.95)201.32 (30.45)190.54 (25.86)  MAPE0.27 (0.02)0.28 (0.02)0.28 (0.02)0.29 (0.04)0.27 (0.02)  THEIL1.11 (0.28)1.03 (0.29)0.68 (0.21)0.78 (0.22)1.08 (0.26)  BP0.01 (0.01)0.01 (0.01)0.01 (0.01)0.01 (0.02)0.01 (0.01)  VP0.45 (0.05)0.53 (0.06)0.30 (0.07)0.31 (0.0982)0.48 (0.07)  CP0.45 (0.05)0.46 (0.06)0.69 (0.07)0.68 (0.0986)0.69 (0.07)Morbidity  MAE12.78 (0.90)12.79 (0.91)13.09 (0.92)13.12 (1.03)12.5 (0.90)  MSE268.26 (39.43)268.86 (39.51)282.71 (42.13)288.41 (45.92)260.34 (39.32)  MAPE0.26 (0.02)0.26 (0.02)0.26 (0.02)0.28 (0.04)0.25 (0.02)  THEIL1.12 (0.28)1.02 (0.26)0.71 (0.21)0.67 (0.22)1.09 (0.25)  BP0.01 (0.01)0.01 (0.01)0.01 (0.01)0.03 (0.04)0.01 (0.02)  VP0.45 (0.06)0.50 (0.06)0.3 (0.08)0.28 (0.08)0.48 (0.07)  CP0.45 (0.06)0.49 (0.06)0.7 (0.08)0.69 (0.09)0.51 (0.07)Values in parentheses are standard deviation

Figure [4](#Fig4){ref-type="fig"} illustrates the combination forecasting model for lung cancer mortality and morbidity, due to exposure to PM~2.5~, where the red color represents high lung cancer mortality and morbidity and the blue color indicates low lung cancer mortality and morbidity. The overall forecasting lung cancer morbidity and mortality were 47.63, 47.86, 39.38, and 39.76 per 100,000 population. In general, the mortality and morbidity of lung cancer show distinct spatial patterns and strong variations across China. High lung cancer mortality and morbidity rates were observed in the north China plain, central China, the Sichuan Basin, and the Guangdong-Guangxi regions. In addition, the spatial distribution of lung cancer mortality and morbidity shows similar patterns for PM~2.5~ concentration.Fig. 4Forecasted lung cancer mortality and morbidity in China from 2015 to 2016

Discussions {#Sec16}
===========

In this study, we aim to forecast the spatial distribution of lung cancer morbidity and mortality in China in 2015 and 2016 due to exposure to PM~2.5~ concentration. We found that the current and previous 8-year PM~2.5~ concentration of local area and surrounding areas was significantly associated with lung cancer mortality and morbidity across China. This enables us to establish several statistical forecast models using both local and surrounding PM~2.5~ concentrations to predict the spatial distribution of lung cancer mortality and morbidity in China. Results showed that the combined forecasting model identified the best performance among five alternative models, besides a similar spatial distribution in morbidity and mortality of lung cancer in 2015 and 2016, with high lung cancer morbidity and mortality areas mainly located in the central to east coast districts.

In recent years, the occurrence of PM~2.5~ pollution has caught much attention and it is recognized that severe PM~2.5~ pollution is not a phenomenon specifically localized to a county or city (Li et al. [@CR21]). Rather, previous studies have illustrated that PM~2.5~ pollution is the result of local pollutants superposed on background regional pollution, which has now expanded into a larger problem of a regional scale (Hu et al. [@CR15]; Fu et al. [@CR11]). Additionally, when meteorological conditions are favorable for the regional transportation of PM pollutants, this leads to a regional scale of PM pollution. In China, PM pollution is strongly affected by anthropogenic activities, including power generation, industrial processes, fossil and biomass fuel or agricultural waste combustion, and vehicle exhaust emissions (Li et al. [@CR21]). Massive amounts of primary PM and high emissions of gas pollutants in densely distributed mega-cities have worsened PM pollution, which has contributed to regional air pollution (Zheng et al. [@CR40]). Moreover, once regional pollution is formed, areas within the region cannot mitigate their pollution solely by reducing local emissions.

Given that the PM~2.5~ has been demonstrated to be a contributor to lung cancer, it can be concluded that the impact of PM~2.5~ regional transport on lung cancer should also be considered. In the present study, we found a significant association between lung cancer outcomes (mortality and morbidity) and PM~2.5~ from regional areas. Furthermore, compared with the local lag exposure to ambient PM~2.5~, the regional lag effect was not stronger than the local PM~2.5~ exposure. One of the main reasons we have taken the regional lag effect of PM~2.5~ pollutant into consideration was internal migration. According to the census in 2010 and national population sampling surveys of 2005 and 2015, nearly 66.64% of internal migrants traveling within provinces and most of them migrate to BTH, the Yangtze River delta, and the Pearl River Delta. Thus, the surrounding areas PM~2.5~ pollutant would like to exert influence on local lung cancer mortality and morbidity indirectly. Importantly, with the reform of the household register system (*hukou* system), there has been massive internal migration from rural to prosperous economic regions, as people seek higher income and better lifestyle opportunities in China (Mou et al. [@CR25]). As a result, the regional transport of PM~2.5~ pollution appeared to be a factor leading to growing lung cancer mortality and morbidity.

In the present study, the short- and long-term exposure to PM~2.5~ concentration was used to establish five forecasting models. However, it is noteworthy that there would exist multi-collinearity problem when two or more predictor variables in a statistical model are linearly related. Furthermore, due to the changed patterns of collinearity, statistical inference using various geographic scales of sampled data leads to serious errors (Dormann et al. [@CR8]). Based on the results of five forecasting models, the combined forecasting model identified the best performance in the lung cancer mortality and morbidity forecast. Consistent with the previous research, the combined forecasting model could improve forecast accuracy that the component forecasts contain useful and independent information (Armstrong [@CR2]). Generally, the combined forecasts require deciding which forecasting model to include. Due to a lack of good knowledge on which forecasting method should be included and in order to generate independent forecasting combinations, we combined two types of forecasting methods: linear regression models and machine learning methods. Existing works on the multi-collinearity problem found that penalized methods such as ridge and lasso were performed well (Vigneau et al. [@CR34]; Tibshirani [@CR29]). Thus, we used the coefficient of the variation method rather than equal weight to establish the combined forecasting model.

One interesting founding is that the ridge regression and partial least squares regression were outperformed model tree and regression tree. When modeling the PM-lung cancer relationship, one important issue that needs to be considered is how to interpret the PM exposure accurately and precisely. However, those machine learning methods where the parameter estimation methods are quite different and do not provide interpretable parameter estimates and standard errors (Hastie [@CR14]). More importantly, compared with linear regression methods, machine learning methods also have the same problems that the model is sensitive to slight changes in data set, due to multi-collinear among variables; it is difficult to interpret the parameter estimation and to separate the effects of multi-collinearity (Shan, Paull, and McKay [@CR27]).

There are some limitations. Firstly, in the present study, the mean values of the PM~2.5~ concentration of neighborhoods were used to characterize the impact of regional transportation of PM~2.5~ over a short distance. However, it is noted that the PM~2.5~ were either from nearby cities, towns, and villages or from remote areas through long-range transport. Meanwhile, the regional transportation of PM~2.5~ was also influenced by wind directions. Therefore, under the different distances and wind directions, we could hardly quantify the impact of regional transportation of PM~2.5~ by the mean value. Secondly, to obtain a more realistic spatial distribution of lung cancer morbidity and mortality, the dust- and sea salt-removed annual PM~2.5~ concentration datasets were used to establish the forecasting models. Thus, we might underestimate the predicted lung cancer morbidity and mortality. Finally, we did not control the smoking population, as smoking data at the county or city level were not available.

Conclusions {#Sec17}
===========

In summary, the present study demonstrated that the short- and long-term exposure to PM~2.5~ concentrations of the local area and regional areas were significantly associated with lung cancer mortality and morbidity across China, and compared with the local lag and regional lag exposure to ambient PM~2.5~, the regional lag effect (0.172\~0.235 for mortality; 0.146\~0.249 for morbidity) was not stronger than the local lag PM~2.5~ exposure (0.249\~0.294 for mortality; 0.215\~0.301 for morbidity). Results from spatial autocorrelation showed that the mortality and morbidity of lung cancer and PM~2.5~ concentration were significantly and spatially correlated for each year in China. Meanwhile, we also found a spatial association between lung cancer morbidity and mortality and satellite-derived PM~2.5~ concentration. Additionally, the sensitivity analysis and forecasting model in the present study provide a useful tool in the risk assessment of PM~2.5~. The spatial-temporal distribution of lung cancer morbidity and mortality and PM~2.5~ concentration will provide scientific support to government agencies and stakeholders. Furthermore, due to the impact of regional transportation on M~2.5~ and internal migration, it is necessary to strengthen regional collaborative pollution management among the high PM~2.5~ concentration regions.
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